Federal Circuit Reiterates That Nucleotide Sequences Are Not Patent Eligible under 35 U.S.C. § 101

December 27, 2018IP Litigator

An article by Matthew Barnet on "Federal Circuit Reiterates That Nucleotide Sequences Are Not Patent Eligible under 35 U.S.C. § 101" is published in the IP Litigator journal.

Resources